TOXOPLASMOSIS AMONG SCHIZOPHRENIC PATIENTS

Investigation of the possible relation between seropositivity to anti-Toxoplasma immunoglobulin-G, peripheral dopamine, cortisol, and oxidative stress in Egyptian schizophrenic p

SEROPREVALENCE OF TOXOPLASMA GONDII IN SCHIZOPHRENIC PATIENTS VERSUS HEALTHY INDIVIDUALS AND ITS POSSIBLE IMPACT ON HUMAN SERUM DOPAMINE LEVEL

Insights into the interplay of latent toxoplasmosis, testosterone, cortisol and oxidative stress in screened schizophrenic patients in Egypt

Investigation of the effect of latent toxoplasmosis on oxidative stress in acne vulgaris patients

Behavior and neuropsychiatric changes in experimental chronic toxoplasmosis: Histopathological and immunohistochemical studies

SEROPREVALENCE OF TOXOPLASMA GONDII INFECTION AND ITS ASSOCIATED RISK FACTORS IN NEUROPSYCHIATRIC PATIENTS IN JAZAN PROVINCE, SAUDI ARABIA

SERO-PREVALENCE OF ANTI- TOXOPLASMA GONDII ANTIBODIES AMONG PATIENTS WITH NEUROPSYCHIATRIC DISORDERS: EPILEPSY AND DEPRESSION

Seroprevalence of Toxoplasma gondii antibodies using Sabin- Feldman dye test among equines in Isparta province, Turkey

Investigating the potential link between seroprevalence of Toxoplasma IgG and both types of diabetes mellitus in Benha city, Egypt